Pirjo Merilahti is a dynamic and accomplished Technology Manager at 3PBIOVIAN, a leading contract development and manufacturing organization specializing in advanced therapies. With a strong background in virology, biotechnology and a passion for innovation, Pirjo brings a wealth of expertise to the field of advanced therapies.
Having worked in the biopharmaceutical industry for almost a decade, Pirjo has a proven track record of driving successful technology development projects from concept to large-scale GMP manufacturing. Pirjo's areas of specialization include gene therapies, viral vectors, and bioprocess development. She is known for her collaborative approach, working closely with cross-functional teams to overcome challenges and optimize processes for the efficient production of advanced therapies. Her commitment to excellence and continuous learning make her a valuable asset in the rapidly evolving field of advanced therapies.
At Advanced Therapies UK 2026, Pirjo Merilahti will share her insights and expertise on the manufacturing of advanced therapies. Attendees can expect to gain valuable knowledge and inspiration from Pirjo's presentation, as she continues to drive progress and innovation in the field of manufacturing of advanced therapies.